Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
阿特珠单抗、贝伐珠单抗和化疗治疗新诊断的 III 期或 IV 期卵巢癌:安慰剂对照随机 III 期试验 (IMagyn050/GOG 3015/ENGOT-OV39)
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.00306
Moore, Kathleen N; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Anderson, Charles; Scambia, Giovanni; Myers, Tashanna; Taskiran, Cagatay; Robison, Katina; Mäenpää, Johanna; Willmott, Lyndsay; Colombo, Nicoletta; Thomes-Pepin, Jessica; Liontos, Michalis; Gold, Michael A; Garcia, Yolanda; Sharma, Sudarshan K; Darus, Christopher J; Aghajanian, Carol; Okamoto, Aikou; Wu, Xiaohua; Safin, Rustem; Wu, Fan; Molinero, Luciana; Maiya, Vidya; Khor, Victor K; Lin, Yvonne G; Pignata, Sandro